Home : Unsafe Drugs : Humira

Humira

Humira (Adalimumab) is an immunosuppresant, approved by the FDA for the treatment of Crohn's Disease, rheumatoid arthritis, and juvenile arthritis. It is administered through a subcutaneous injection.

The most common side effects of Humira are dry cough, fever, weight loss, fever with chills, body aches, flu symptoms. Patients taking Humira are at increased risk for serious adverse effects, including serious infections that can lead to hospitalization or death. Because Humira affects the immune system, it can lower the body's ability to fight infections, such as tuberculosis and other opportunistic infections. Humira is a blocker of TNF (tumor necrosis factor) and may cause lymphomas (a form of cancer) and other malignancies.

Recently, Humira was given a Black Box Label Warning by the FDA. The Black Box Warning is the strongest warning label a drug can have applied to it. Drugs that carry a high risk of serious side effects or potentially deadly adverse reactions are given this warning. This label is given only after medical studies have indicated that there are serious risks associated with the side effects of the medication.

Fast Facts

Name: Humira
Generic: Adalimumab
Manufacturer: Abbott Laboratories
Date approved: 2002
Status: Prescription Only - Black Box Warning Label
Approved uses: Treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, moderate to severe chronic psoriasis and juvenile idiopathic arthritis.
Off-Label uses: None
Side effects: Feeling short of breath, even with mild exertion; swelling of your ankles or feet; red, purple, or scaly skin rash, hair loss, joint or muscle pain, mouth sores; confusion, seizure (convulsions); pain or burning when you urinate; numbness or tingly feeling, weakness in your legs; or jaundice (yellowing of the skin or eyes). Potentially Deadly Serious Fungal Infection has been reported recently by the FDA.
Related topics: Cimzia, Enbrel, Remicade
Do you need a District of Columbia Humira attorney? Contact one of our District of Columbia Humira attorneys now.

FDA Announces Black Box Label Warning for Humira

In early September, 2008, the FDA announced it would require stronger warnings for four medications commonly used in the treatment of rheumatoid arthritis. The warning label is known as the... read more

View the Humira Main Articles page here

FDA Information Related to Humira

February 2007 Monthly Safety Labeling

FDA Approves New Treatment For Crohn's Disease

View the Humira FDA Information page here

MSN Newsfeeds Related to Humira

Enhanze Technology Clinical Trial Demonstrated Improved Absorption

Halozyme Therapeutics Reports Positive Results For Enhanze Technology ...

View the Humira MSN Newsfeeds page here

News Articles Related to Humira

DIREVO announces validation of bestMab(TM)

News and Press release service TransWorldNews

View the Humira News Articles page here

Wikipedia Entries Related to Humira

Adalimumab

Monoclonal antibodies

View the Humira Wikipedia Entries page here

Books Related to Humira

Famvir, Humira.(NEW & APPROVED)(drug licensing)(drug overview): An article from: Family Practice News

Biologic therapy for psoriasis: an update on the tumor necrosis factor inhibitors infliximab, etanercept, and adalimumab, and the T-Cell-targeted therapies ... from: Journal of Drugs in Dermatology

View the Humira Books page here

Do you need a District of Columbia Humira attorney? Contact one of our District of Columbia Humira attorneys now.

AddThis Social Bookmark Button

 

Need A Humira Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury
Click to Ask a Question

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Need A Humira Lawyer?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury
Click to Ask a Question

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Humira Case - Submit Your Information Below

Do you need legal assistance with your Humira case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Humira Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.
This form is secure and encrypted. More information about secure forms and your privacy here.